• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Journal of European CME >Developing an appropriately supported CME-accredited programme in Europe
【24h】

Developing an appropriately supported CME-accredited programme in Europe

机译：在欧洲开发得到适当支持的CME认证计划

获取原文
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Abstract Objectives: The Lupus Academy was established as an independent, consortium-led continuing medical education (CME) initiative for physicians interested in the pathogenesis, diagnosis and management of patients with systemic lupus erythematosus (SLE) and related conditions, based on identification of an unmet clinical need. The Lupus Academy is intended to be a long-term enterprise that is committed to sharing best practice in the field of lupus. Challenge: European CME remains in its infancy and many regulatory aspects are yet to be finalised. Pharmaceutical company supporters must be willing to adopt an ‘arms length’ approach to funding to ensure that educational programmes are truly independent, whilst funding must be spent in an appropriate and ethical manner by education providers. This review manuscript describes the innovative approach of the Lupus Academy within the global CME environment; illustrates the interactions between pharmaceutical supporters, clinicians, education providers and support organisations, in adherence to international guidance; and shows how a pharmaceutical company can support a CME activity whilst satisfying the external regulatory environment. Project structure: The Lupus Academy was created by a Steering Committee of six international experts with funding from GlaxoSmithKline and Human Genome Sciences and support from three organisations to facilitate the delivery of logistics, medical education materials, and CME compliance and financial management. Together, these groups formed a Consortium in which all parties took equal and collective responsibility for the success of the programme, from content development to regulatory compliance, CME adherence and financial management. How and where the meeting took place: The Inaugural Meeting of the Lupus Academy took place in Barcelona, Catalonia, Spain in 2012. Programme content and learning objectives for the 1.5-day meeting were developed by a Steering Committee based on clinical training needs and advances in lupus, and the 17-strong expert faculty was selected by the Steering Committee. The Consortium worked with national and international lupus organisations to identify appropriate clinicians to attend the meeting; a broad range of delegates were attracted to the meeting from across a wide range of disciplines, including rheumatology, nephrology, dermatology, clinical immunology and internal medicine. Outcomes and results: The Inaugural Meeting included plenary sessions and interactive workshops with keypad voting to promote interactivity and delegate participation. The meeting was attended by 296 delegates from 30 countries across Europe, the Americas and the Asia Pacific region. Most delegates rated the educational content, meeting objectives and logistics of the meeting highly. Almost all delegates stated a preference for independent educational initiatives compared with pharmaceutical-controlled events and most delegates considered the absence of commercial bias to be important. Many of the delegates indicated that they would change their clinical practice based on what they learnt from the meeting. Conclusions and future objectives: The Inaugural Meeting of the Lupus Academy was considered a success by the Consortium members and financial supporters. The overall approach to the initiative, including the structure of the Consortium, the independence of the high-quality educational programme, the financial management and CME accreditation, was considered the key to its success. This long-term enterprise will continue as an annual event, with interactive workshops forming a greater part of future programmes to allow delegates to share clinical experiences. The second Annual Meeting of the Academy took place in Buenos Aires, Argentina in April 2013, the third is being planned for Berlin, Germany in March 2014.
机译：摘要目的：建立狼疮学院是一项独立的，由联合体主导的继续医学教育（CME）计划，旨在对对系统性红斑狼疮（SLE）及其相关病症的发病机理，诊断和治疗感兴趣的医生，未满足临床需求。狼疮学院旨在成为一个长期的企业，致力于分享狼疮领域的最佳实践。挑战：欧洲CME仍处于起步阶段，许多监管方面尚未最终确定。制药公司的支持者必须愿意采用“公平的方式”筹集资金，以确保教育计划真正独立，而资金必须由教育提供者以适当且符合道德的方式花费。这份评论稿描述了狼疮学院在全球CME环境中的创新方法;说明遵守国际指导的药物支持者，临床医生，教育提供者和支持组织之间的互动;并展示了制药公司如何在满足外部法规环境的同时支持CME活动。项目结构：狼疮学院是由六名国际专家组成的指导委员会创建的，由葛兰素史克公司和人类基因组科学基金会提供资金，并得到三个组织的支持，以促进物流，医学教育资料以及CME合规性和财务管理的交付。这些团体共同组成了一个财团，所有参与者对计划的成功负有同等和集体的责任，从内容开发到法规遵从，CME遵守和财务管理。会议的召开方式和地点：狼疮学院的成立大会于2012年在西班牙加泰罗尼亚的巴塞罗那举行。为期1.5天的会议的计划内容和学习目标是由指导委员会根据临床培训的需求和进展制定的在狼疮，由指导委员会选拔了由17人组成的专家学院。财团与国家和国际狼疮组织合作，确定合适的临床医生参加会议。风湿病学，肾脏病学，皮肤病学，临床免疫学和内科等众多学科吸引了众多与会代表。结果和结果：成立大会包括全体会议和互动式研讨会，并通过键盘投票来促进互动性和与会代表的参与。来自欧洲，美洲和亚太地区30个国家的296名代表参加了会议。大多数代表对会议的教育内容，会议目标和会议安排给予了高度评价。与药品控制的活动相比，几乎所有代表都表示更倾向于独立的教育计划，并且大多数代表认为缺乏商业偏见是重要的。许多代表表示，他们将从会议中学到的知识改变他们的临床实践。结论和未来目标：狼疮学会成立大会被财团成员和财务支持者认为是成功的。该倡议的总体方法，包括财团的结构，高质量教育计划的独立性，财务管理和CME认证，被认为是其成功的关键。这个长期的企业将继续作为一年一度的活动，交互式讲习班将成为未来计划的重要组成部分，以使与会代表可以分享临床经验。该学院的第二届年会于2013年4月在阿根廷布宜诺斯艾利斯举行，第三届年会计划于2014年3月在德国柏林举行。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号